214 related articles for article (PubMed ID: 16998760)
1. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
3. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
4. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Stangel M; Gold R
Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
[TBL] [Abstract][Full Text] [Related]
5. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin therapy in neurological diseases during pregnancy.
Ringel I; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V70-4. PubMed ID: 16998758
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulins and physiopathology: actual indications].
Mouthon L; Guilpain P
Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
[TBL] [Abstract][Full Text] [Related]
9. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
Dalakas MC
J Neurol; 2006 Sep; 253 Suppl 5():V25-32. PubMed ID: 16998751
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
11. Advances in the use of IVIg in neurological disorders.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():1-2. PubMed ID: 18685918
[No Abstract] [Full Text] [Related]
12. [High Dose Intravenous Immunoglobulin Therapy for Autoimmune Diseases of the Central Nervous System].
Uzawa A; Kuwabara S
Brain Nerve; 2021 May; 73(5):420-424. PubMed ID: 34006671
[TBL] [Abstract][Full Text] [Related]
13. [Current indications of polyvalent immunoglobulins].
Magy L
Bull Acad Natl Med; 2012 Jan; 196(1):49-60; discussion 61. PubMed ID: 23259332
[TBL] [Abstract][Full Text] [Related]
14. The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders.
Souayah N; Hasan A; Khan HM; Yacoub HA; Jafri M
J Clin Neuromuscul Dis; 2011 Jun; 12 Suppl 4():S1-10. PubMed ID: 22361589
[TBL] [Abstract][Full Text] [Related]
15. Therapy with intravenous immunoglobulins: complications and side-effects.
Wittstock M; Benecke R; Zettl UK
Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
[TBL] [Abstract][Full Text] [Related]
16. Regulatory and reimbursement issues in treating patients with immune-mediated neuropathies.
Donofrio PD; Busis NA
Neurology; 2002 Dec; 59(12 Suppl 6):S41-5. PubMed ID: 12499470
[TBL] [Abstract][Full Text] [Related]
17. [Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006].
Guillevin L
Rev Med Interne; 2007 May; 28 Spec No. 1():1-3. PubMed ID: 17768830
[TBL] [Abstract][Full Text] [Related]
18. Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study.
Stangel M; Kiefer R; Pette M; Smolka MN; Marx P; Gold R
J Neurol; 2003 Jul; 250(7):818-21. PubMed ID: 12883923
[TBL] [Abstract][Full Text] [Related]
19. Clinical Applications of Intravenous Immunoglobulins in Child Neurology.
Gogou M; Papadopoulou-Alataki E; Spilioti M; Alataki S; Evangeliou A
Curr Pharm Biotechnol; 2017 Nov; 18(8):628-637. PubMed ID: 28914199
[TBL] [Abstract][Full Text] [Related]
20. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
